An interventional study of Dextrose 40 % in Water and Adrenaline 1 Mg/mL Solution for Injection in Gastro Intestinal Bleeding, sponsored by Dr Cipto Mangunkusumo General Hospital. Status unknown at 1 site in Indonesia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-07-28.
Sponsored by Dr Cipto Mangunkusumo General Hospital · Not applicable, Interventional, and Treatment
This study is conducted to evaluate the effectivity of hypertonic dextrose spray as an endoscopic topical hemostatic agent, compared to conventional agent (adrenaline injection, followed by hemoclip or thermocoagulation), in patients with acute non-variceal upper GI bleeding.
339 studies on the registry are indexed under Gastrointestinal Hemorrhage; 79 are open to participants now.
This study's planned enrollment of 66 is below the median of 87 across 211 interventional studies indexed under Gastrointestinal Hemorrhage.
Browse Gastrointestinal Hemorrhage studies →Dr Cipto Mangunkusumo General Hospital is the lead sponsor of 37 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients within control group will be given adrenaline 1:20.000 injection, followed by thermocoagulation or hemoclip
Drug: Adrenaline 1 Mg/mL Solution for Injection · Procedure: argon plasma coagulation · Procedure: Hemoclip
Patients within this group will be given adrenaline 1:20.000 injection, followed by dextrose 40% spray
Drug: Dextrose 40 % in Water · Drug: Adrenaline 1 Mg/mL Solution for Injection
injection of adrenaline 1:20.000, followed by dextrose 40% spray
injection of adrenaline 1:20.000, followed by thermocoagulation or hemoclip
Thermocoagulation
Hemoclip
Hemostatic success
Number of participants whose bleeding stops within five minutes after intervention is given. Outcome is assessed by independent assessor (not the endoscopy operator), who also attend the endoscopy session and could observe whether the bleeding stops.
Time frame: 5 minute
Re-bleeding
Number of participants who experience decrease in hemoglobin \>1g/dl or need additional hemostatic endoscopy within one week after intervention
Time frame: 7 days
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dr Cipto Mangunkusumo General Hospital